scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0008-6363(01)00306-6 |
P698 | PubMed publication ID | 11470468 |
P50 | author | Alfredo Grilli | Q59706004 |
P2093 | author name string | R De Caterina | |
A Barsotti | |||
P Di Napoli | |||
M Felaco | |||
R Spina | |||
A Antonio Taccardi | |||
P433 | issue | 2 | |
P921 | main subject | simvastatin | Q670131 |
reperfusion injury | Q1413991 | ||
P304 | page(s) | 283-293 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts | |
P478 | volume | 51 |
Q33263170 | A preliminary study of healing of diode laser versus scalpel incisions in rat oral tissue: a comparison of clinical, histological, and immunohistochemical results |
Q44959320 | AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction |
Q34116819 | Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx |
Q35584237 | Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure |
Q46601568 | Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats |
Q46795298 | Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats |
Q44307951 | Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway |
Q43211132 | Changes in PPAR gene expression and myocardial tolerance to ischaemia: relevance to pleiotropic effects of statins |
Q36081210 | Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins |
Q44687808 | Differential in vitro response of the human radial artery versus left internal thoracic artery to cerivastatin: implications to bypass grafting |
Q46382042 | Donor simvastatin treatment prevents ischemia-reperfusion and acute kidney injury by preserving microvascular barrier function |
Q44739752 | Effect of angiotensin II type 2 receptor blockade on activation of mitogen-activated protein kinases after ischemia-reperfusion in isolated working rat hearts |
Q47632901 | Effect of chronic hypoxia on inducible nitric oxide synthase expression in rat myocardial tissue |
Q38916494 | Effect on eNOS/NO Pathway in MIRI rats with preconditioning of GFPC from Dang Gui Si Ni decoction |
Q44037878 | Effects of cerivastatin on vascular function of human radial and left internal thoracic arteries |
Q28580295 | Effects of simvastatin on cardiac performance and expression of sarcoplasmic reticular calcium regulatory proteins in rat heart |
Q82894640 | Effects of simvastatin on cardiohemodynamic responses to ischemia-reperfusion in isolated rat hearts |
Q24806340 | Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696] |
Q37941943 | Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? |
Q46687759 | Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts |
Q36836771 | Myocardial protection in man--from research concept to clinical practice |
Q34424756 | Netrin-1 improves post-injury cardiac function in vivo via DCC/NO-dependent preservation of mitochondrial integrity, while attenuating autophagy |
Q24624234 | Netrin-1 prevents ischemia/reperfusion-induced myocardial infarction via a DCC/ERK1/2/eNOS s1177/NO/DCC feed-forward mechanism |
Q47880717 | Nitric oxide synthase in healthy and inflamed human dental pulp |
Q37014196 | Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review |
Q37522854 | Occult cardiotoxicity--toxic effects on cardiac ischemic tolerance |
Q45241719 | Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level. |
Q34515458 | Pharmacological approaches to preserving and restoring coronary endothelial function |
Q37033172 | Predictors of preinterventional patency of infarct-related artery in patients with ST-segment elevation myocardial infarction: Importance of neutrophil to lymphocyte ratio and uric acid level |
Q34967386 | Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. |
Q36836773 | Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. |
Q37445518 | Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease |
Q47681698 | Role of inducible nitric oxide synthase in myocardial ischemia-reperfusion injury in sleep-deprived rats |
Q53594601 | Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial. |
Q46495061 | Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore |
Q46869160 | Rosuvastatin provides pleiotropic protection against pulmonary hypertension, right ventricular hypertrophy, and coronary endothelial dysfunction in rats |
Q36953912 | Simvastatin inhibits central sympathetic outflow in heart failure by a nitric-oxide synthase mechanism |
Q35230306 | Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism |
Q35762325 | Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat |
Q43215640 | Statins and modulation of oxidative stress. |
Q37611724 | Statins as anti-arrhythmics: a systematic review part II: effects on risk of ventricular arrhythmias. |
Q36768488 | Statins as first-line therapy for acute coronary syndrome? |
Q37276466 | Statins in the first-line therapy of acute coronary syndrome - similar to aspirin? |
Q38832154 | Systemic and local anti-nociceptive effects of simvastatin in the rat formalin assay: Role of peroxisome proliferator-activated receptor γ and nitric oxide. |
Q38228143 | The effects of statin medications on aerobic exercise capacity and training adaptations. |
Q57225466 | Threshold level of low-density lipoprotein cholesterol for the short-term benefit of statin therapy in the acute phase of myocardial infarction |
Search more.